Establishment of FUT8 knockout Chinese hamster ovary cells:: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity

被引:413
作者
Yamane-Ohnuki, N [1 ]
Kinoshita, S [1 ]
Inoue-Urakubo, M [1 ]
Kusunoki, M [1 ]
Iida, S [1 ]
Nakano, R [1 ]
Wakitani, M [1 ]
Niwa, R [1 ]
Sakurada, M [1 ]
Uchida, K [1 ]
Shitara, K [1 ]
Satoh, M [1 ]
机构
[1] Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, Machida, Tokyo 1948533, Japan
关键词
Chinese hamster ovary (CHO) cells; FUT8; knockout; alpha-1,6-fucosylation; therapeutic antibody; antibody-dependent; cellular cytoxicity (ADCC);
D O I
10.1002/bit.20151
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To generate industrially applicable new host cell lines for antibody production with optimizing antibody-dependent cellular cytotoxicity (ADCC) we disrupted both FUT8 alleles in a Chinese hamster ovary (CHO)/DG44 cell line by sequential homologous recombination. FUT8 encodes an alpha-1 6-fucosyltransferase that catalyzes the transfer of fucose from GDP-fucose to N-acetylglucosamine (GlcNAc) in an alpha-1,6 linkage. FUT8(-/-) cell lines have morphology and growth kinetics similar to those of the parent, and produce completely defucosylated recombinant antibodies. FUT8(-/-)-produced chimeric anti-CD20 IgG1 shows the same level of antigen-binding activity and complement-dependent cytotoxicity (CDC) as the FUT8(+/+)-produced, comparable antibody, Rituxan. In contrast, FUT8(-/-)-produced anti-CD20 IgG1 strongly binds to human Fcgamma-receptor IIIa (FcgammaRIIIa) and dramatically enhances ADCC to approximately 100-fold that of Rituxan. Our results demonstrate that FUT8(-/-) cells are ideal host cell lines to stably produce completely defucosylated highADCC antibodies with fixed quality and efficacy for therapeutic use. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:614 / 622
页数:9
相关论文
共 49 条
[1]   TARGETED HOMOLOGOUS RECOMBINATION AT THE ENDOGENOUS ADENINE PHOSPHORIBOSYLTRANSFERASE LOCUS IN CHINESE-HAMSTER CELLS [J].
ADAIR, GM ;
NAIRN, RS ;
WILSON, JH ;
SEIDMAN, MM ;
BROTHERMAN, KA ;
MACKINNON, C ;
SCHEERER, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4574-4578
[2]   The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus [J].
Anolik, JH ;
Campbell, D ;
Felgar, RE ;
Young, F ;
Sanz, I ;
Rosenblatt, J ;
Looney, RJ .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :455-459
[3]   END EXTENSION REPAIR OF INTRODUCED TARGETING VECTORS MEDIATED BY HOMOLOGOUS RECOMBINATION IN MAMMALIAN-CELLS [J].
ARATANI, Y ;
OKAZAKI, R ;
KOYAMA, H .
NUCLEIC ACIDS RESEARCH, 1992, 20 (18) :4795-4801
[4]   GENE TARGETING IN NORMAL SOMATIC-CELLS - INACTIVATION OF THE INTERFERON-GAMMA RECEPTOR IN MYOBLASTS [J].
ARBONES, ML ;
AUSTIN, HA ;
CAPON, DJ ;
GREENBURG, G .
NATURE GENETICS, 1994, 6 (01) :90-97
[5]   The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H [J].
Boyd, PN ;
Lines, AC ;
Patel, AK .
MOLECULAR IMMUNOLOGY, 1995, 32 (17-18) :1311-1318
[6]   Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].
Cartron, G ;
Dacheux, L ;
Salles, G ;
Solal-Celigny, P ;
Bardos, P ;
Colombat, P ;
Watier, H .
BLOOD, 2002, 99 (03) :754-758
[7]   Industrial choices for protein production by large-scale cell culture [J].
Chu, L ;
Robinson, DK .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :180-187
[8]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[9]   ANALYSIS OF BIOLOGICAL SELECTIONS FOR HIGH-EFFICIENCY GENE TARGETING [J].
HANSON, KD ;
SEDIVY, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) :45-51
[10]  
Hasty P., 1993, Gene targeting: a practical approach., P1